Rectal cancer disappears after immunotherapy: FDA nod | First ingestion of new PillCam? Genius SB Kit | Cuts: Anthem GI anesthesia reimbursements
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Buy The Shift on your local Amazon here: https://geni.us/TheShiftBySuthrum.
Congress has unveiled a year-end legislative package that nearly eliminates a looming Medicare physician payment cut.
What happened when Anthem cut GI anesthesia reimbursements? (Becker’s GI & Endoscopy)
Recent controversies over anesthesia reimbursement have underscored the precarious balance between insurers’ cost-cutting measures and the necessity of fairly compensating providers for complex gastrointestinal (GI) procedures.
US Digestive Health Welcomes 19 New Advanced Practice Providers (APPs) to Its Network (GlobeNewswire)
The APPs will support USDH’s expansion throughout Pennsylvania and Delaware.
Tips on Whether a GI Hospitalist Role Is Right for You or Your Hospital (GI & Endoscopy News)
This model enhances efficiency by allowing outpatient gastroenterologists to focus on their practices while ensuring that hospitalized patients receive specialized, immediate attention.
Telehealth provider Ro will begin offering single-dose vials of Eli Lilly’s newly approved obesity drug, Zepbound, aiming to streamline access for patients.
FoodMarble targets new growth as it plans US expansion (The Irish Times)
Irish start-up FoodMarble, creator of a handheld digestive breath analyzer called Aire, is expanding its team, focusing on the US healthcare market, and expecting around €4 million in annual revenue.
The Memo: Satisfai Health Advancing GI Care Through AI-Powered Precision Medicine (Life Science Intelligence)
Armed with $9.4 million in Series A funding and strong clinical and industry connections, Satisfai Health plans to launch Certai for research applications in 2025.
领英推荐
Rectal Cancer Disappears After Experimental Use of Immunotherapy, Now an FDA Designated Breakthrough Therapy (Memorial Sloan Kettering Cancer Center)
A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) led to the FDA granting a Breakthrough Therapy Designation to Jemperli (dostarlimab), an immunotherapy drug for treating a subset of rectal cancer patients.
National Healthcare Spending in the U.S. Was Nearly $5 Trillion (with a “T”) in 2023 – New Data from CMS (Health Populi)
U.S. national health spending hit $4.9 trillion in 2023, a figure that’s on par with the entire economies of major countries and large multinational corporations.
Clinical Practice Updates: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight (Inside Scope)
This episode shares key insights from the AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease.
Medtronic has announced the successful first patient procedure using its next-generation PillCam? Genius SB Kit at the University of Miami Health System.
Gastro Concepts Receives FDA Clearance for Air Assist? Device, Revolutionizing Colonoscopy Procedures (PR Newswire)
Gastro Concepts announced FDA 510(k) clearance for its innovative Air Assist? device, a disposable tool designed to enhance colonoscopy safety.
The study evaluated the impact of differing false positive (FP) rates in two computer-aided detection (CADe) systems on the clinical effectiveness of artificial intelligence (AI)-assisted colonoscopy.
International researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically with ulcerative colitis (UC) and Crohn’s disease (CD).
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.
Get the books: